Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Purdue discloses antitumor selenophene compounds

March 5, 1998

Colchicine analogues from Indena show potential for resistant tumors

March 5, 1998

Chemopotentiating agents in R&D at Nippon Flour Milling

March 5, 1998

Gliadel Wafer approved for marketing in Brazil

March 4, 1998

BOPP will enter clinical testing in cancer patients

March 4, 1998

Searle uses Epimmune technologies to develop cancer therapies

March 4, 1998

Status of Oncolym updated

March 4, 1998

Select Therapeutics licenses cancer-related technology

March 3, 1998

Cell Pathways/U. of Arizona study compounds for precancerous lesions

March 3, 1998

Penclomedine metabolite shows comparable anticancer efficacy, reduced neurotoxicity

March 3, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...